Bioventus
BVS
105 hedge funds and large institutions have $447M invested in Bioventus in 2022 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 32 increasing their positions, 41 reducing their positions, and 15 closing their positions.
47% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 15
7% more funds holding
Funds holding: 98 → 105 (+7)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
0.13% less ownership
Funds ownership: 52.45% → 52.32% (-0.13%)
1% less capital invested
Capital invested by funds: $452M → $447M (-$4.63M)
22% less repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 41
97% less call options, than puts
Call options by funds: $2K | Put options by funds: $69K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
+$12.1M |
| 2 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$9.46M |
| 3 |
RA
Royce & Associates
New York
|
+$2.07M |
| 4 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$1.32M |
| 5 |
First Eagle Investment Management
New York
|
+$1.29M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
-$6.21M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$5.83M |
| 3 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$3.39M |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$2.21M |
| 5 |
AI
Acuitas Investments
Seattle,
Washington
|
-$1.65M |
BVS Hedge Fund Activity: Q1 2022 in Review
105 of the 6,360 institutional investors tracked by Wall St. Rank reported a position in Bioventus (BVS) for Q1 2022, worth a combined $447M — down 1% from $452M a quarter earlier.
Buyers outnumbered sellers: 22 funds opened new BVS positions and 15 closed out — a net gain of 7 holders — while 32 added to existing stakes and 41 trimmed.
The largest buyer was First Light Asset Management, opening a new position worth an estimated $12.1M. The largest seller was Soleus Capital Management, exiting entirely with an estimated $6.21M sold.
- 105 institutional investors held Bioventus (BVS) as of Q1 2022, up from 98 in Q4 2021.
- Funds reported $447M of Bioventus stock for Q1 2022, down 1% quarter-over-quarter.
- 22 funds opened new Bioventus positions in Q1 2022 and 15 closed out, a net change of +7 holders.
- The largest Bioventus buyer in Q1 2022 was First Light Asset Management, an estimated $12.1M added.
- The largest Bioventus seller in Q1 2022 was Soleus Capital Management, an estimated $6.21M sold.
Based on aggregated 13F filings for Q1 2022.